Hospital in Poland Welcomes Fox Chase Cancer Center Expert Physician
PHILADELPHIA (June 10, 2002) — Michael Unger, MD, FACP, FCCP, Director of the Pulmonary Cancer Detection and Prevention Programand the Pulmonary Endoscopy and High-Risk Lung Cancer Program took his expertise to Poland as the visiting professor at the Silesian Medical University in Katowice. Unger spent time conducting seminars teaching the latest cutting edge diagnostic techniques practiced at Fox Chase Cancer Center for lung and esophageal cancers. Silesian and Fox Chase physicians also discussed the future of collaborative cancer research.
Unger was invited to Silesia to be the keynote speaker at the centennial celebration of the Silesian Medical Association. Unger delivered the address and other lectures in Polish.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.